Hart A - Search Results

1

Solid Organ Transplantation and Survival among Individuals with a History of Cancer.

Engels EA, Haber G, Hart A, Lynch CF, Li J, Pawlish KS, Qiao B, Yu KJ, Pfeiffer RM. Engels EA, et al. Among authors: hart a. Cancer Epidemiol Biomarkers Prev. 2021 Jul;30(7):1312-1319. doi: 10.1158/1055-9965.EPI-21-0044. Epub 2021 Apr 29. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 33926864 Free PMC article.

2

Balancing uncertain risks in candidates for solid organ transplantation with a history of malignancy: Who is safe to transplant?

Hart A, Engels EA. Hart A, et al. Am J Transplant. 2021 Feb;21(2):447-448. doi: 10.1111/ajt.16366. Epub 2020 Nov 10. Am J Transplant. 2021. PMID: 33084186 Free article. No abstract available.

3

Mortality among solid organ waitlist candidates during COVID-19 in the United States.

Miller J, Wey A, Musgrove D, Son Ahn Y, Hart A, Kasiske BL, Hirose R, Israni AK, Snyder JJ. Miller J, et al. Among authors: hart a. Am J Transplant. 2021 Jun;21(6):2262-2268. doi: 10.1111/ajt.16550. Epub 2021 Mar 6. Am J Transplant. 2021. PMID: 33621421 Free PMC article.

4

Predicted Cure and Survival Among Transplant Recipients With a Previous Cancer Diagnosis.

Engels EA, Haber G, Hart A, Lynch CF, Li J, Pawlish KS, Qiao B, Yu KJ, Pfeiffer RM. Engels EA, et al. Among authors: hart a. J Clin Oncol. 2021 Dec 20;39(36):4039-4048. doi: 10.1200/JCO.21.01195. Epub 2021 Oct 22. J Clin Oncol. 2021. PMID: 34678077 Free PMC article.

5

Cardiovascular risk assessment in kidney transplantation.

Hart A, Weir MR, Kasiske BL. Hart A, et al. Kidney Int. 2015 Mar;87(3):527-34. doi: 10.1038/ki.2014.335. Epub 2014 Oct 8. Kidney Int. 2015. PMID: 25296093 Free article. Review.

6

The association between loss of Medicare, immunosuppressive medication use, and kidney transplant outcomes.

Hart A, Gustafson SK, Wey A, Salkowski N, Snyder JJ, Kasiske BL, Israni AK. Hart A, et al. Am J Transplant. 2019 Jul;19(7):1964-1971. doi: 10.1111/ajt.15293. Epub 2019 Mar 5. Am J Transplant. 2019. PMID: 30838768 Free PMC article.

7

Posttransplant outcome assessments at listing: Long-term outcomes are more important than short-term outcomes.

Wey A, Hart A, Salkowski N, Skeans M, Kasiske BL, Israni AK, Snyder JJ. Wey A, et al. Among authors: hart a. Am J Transplant. 2020 Oct;20(10):2813-2821. doi: 10.1111/ajt.15911. Epub 2020 May 5. Am J Transplant. 2020. PMID: 32282985 Free article.

8

Incidence, risk factors, treatment, and consequences of antibody-mediated kidney transplant rejection: A systematic review.

Hart A, Singh D, Brown SJ, Wang JH, Kasiske BL. Hart A, et al. Clin Transplant. 2021 Jul;35(7):e14320. doi: 10.1111/ctr.14320. Epub 2021 May 5. Clin Transplant. 2021. PMID: 33864724 Review.

9

Incidence, risk factors, and long-term outcomes associated with antibody-mediated rejection - The long-term Deterioration of Kidney Allograft Function (DeKAF) prospective cohort study.

Hart A, Schladt DP, Matas AJ, Itzler R, Israni AK, Kasiske BL. Hart A, et al. Clin Transplant. 2021 Jul;35(7):e14337. doi: 10.1111/ctr.14337. Epub 2021 May 18. Clin Transplant. 2021. PMID: 33955070

10

Cost, healthcare utilization, and outcomes of antibody-mediated rejection in kidney transplant recipients in the US.

Hart A, Zaun D, Itzler R, Schladt D, Israni A, Kasiske B. Hart A, et al. J Med Econ. 2021 Jan-Dec;24(1):1011-1017. doi: 10.1080/13696998.2021.1964267. J Med Econ. 2021. PMID: 34348559 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,797 results

Search Page

Filters